Market Research Logo

Indian Peptides and Heparin Market by Type (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis) - Forecast to 2022

Indian Peptides and Heparin Market by Type (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis) - Forecast to 2022

“Indian Peptides and Heparin Market projected to grow at a CAGR of 15.0% and 4.9% respectively”
The Indian peptides market is expected to reach USD 883.0 million in 2022 from USD 381.8 million in 2016 and is expected to register a CAGR of 15.0%, and the Indian heparin market is projected to reach USD 170.2 million by 2022, at a CAGR of 4.9%. Factors such as increasing prevalence of chronic diseases, increasing incidence of coagulation disorder, and favorable government policies are the major driving factors for the Indian peptides and heparin market. On the other hand, the availability of alternative drugs is the major restraining factor for the Indian peptides market. The patent expiry of blockbuster drugs will provide growth opportunities to players in the Indian peptides market. For example, Victorza is the brand name of the liraglutide peptide developed by Novo Nordisk. Its patent will expire in August 2017, which will enable drug manufacturers to introduce their generic versions of it.

“Bivalirudin type is expected to register the highest growth during the forecast period”
The Indian peptides market is classified on the basis of type into insulin, teriparatide, liraglutide, glucagon, leuprolide acetate, octreotide acetate, calcitonin salmon, triptorelin, eptifibatide, glatiramer acetate, bivalirudin, exenatide, and other molecules. The bivalirudin segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the increasing number of percutaneous coronary intervention procedures (PCI) in India.

“Awareness about early diagnosis drives growth of the diabetes segment”
By application, the Indian peptides market is segmented into diabetes, infectious disease, cancer, cardiology, osteoporosis, gynecological applications, and other applications. The diabetes segment is expected to register highest CAGR during the forecast period. The growth in this segment can be primarily attributed to increasing awareness of early diagnosis, increasing prevalence & incidence of diabetes, and increasing aging population.

Key players operating in the Indian peptides market include Abbott Laboratories (U.S.), Sanofi S.A. (France), Eli Lilly and Company (U.S.), Cipla Limited (India), Biocon Limited (India), Intas Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Cadila Pharmaceuticals (India), Lupin Limited (India), Emcure Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Dr. Reddy’s Laboratories Limited (India), and Alkem Laboratories Limited (India).

“Enoxaparin sodium type is expected to register the highest growth during the forecast period”
The Indian heparin market is classified on the basis of type into enoxaparin sodium, heparin sodium, fondaparinux, and dalteparin sodium. The enoxaparin sodium type segment is expected to register the highest growth during the forecast period. This growth can be attributed to the increasing coagulation disorders in the country.

Key players operating in the Indian heparin market include Sanofi (France), Emcure Pharmaceutical Pvt. Ltd. (India), Cipla Ltd. (India), Bharat Serum (India), Pfizer Inc. (U.S.), Abbott Laboratories (U.S.), Lupin Ltd. (India), Dr. Reddy’s Laboratories (India), Intas Pharmaceuticals Ltd. (India), Samarth Life Sciences (India), Claris Lifesciences Limited (India), Gland Pharma Limited (India), Mylan Pharmaceutical (India), Torrent Pharmaceuticals (India), Micro Labs Ltd. (India), and VHB Lifesciences (India).

The primary interviews conducted for this report can be categorized as follows:
• By Company Type - Tier 1 – 70 %, Tier 2 – 30%
• By Designation – C level – 62%, Director level – 21%, Others – 17%

Research Coverage:
The report analyses the Indian peptides market by type and application and the Indian heparin market by type. Apart from comprehensive product analysis and market sizing, the report also provides the complete list of peptide and heparin manufacturers and marketing players in India. In addition, the report profiles companies with product portfolios and key financial data by key players to maintain and increase their shares in the market. The abovementioned market research data, market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.

Benefits of Buying this Report:
This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.
The report provides insights on the following strategies:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the Indian peptides and heparin market. The report analyses the Indian peptides market by type and application and the Indian heparin market by type.
• Competitive Assessment: In-depth assessment of the market strategies, business segments, and product portfolios of the leading players in the Indian peptides and heparin market.


  • INDIAN PEPTIDES MARKET OVERVIEW
    • INTRODUCTION
    • INDIAN PEPTIDES MARKET DYNAMICS
      • DRIVERS
        • Table INCIDENCE OF CANCER CASES IN INDIA, 2015 VS 2025
      • RESTRAINT
        • Table PEPTIDES AND THEIR ALTERNATIVES
      • OPPORTUNITY
      • CHALLENGE
  • INDIAN PEPTIDES MARKET, BY TYPE
    • INTRODUCTION
      • Table INDIAN PEPTIDES MARKET, BY TYPE, 2016-2022 (USD MILLION)
    • INSULIN
      • Table INSULIN MARKET: MANUFACTURERS AND BRANDS
      • Table INSULIN MARKET: KEY PLAYERS AND BRANDS
      • INSULIN MARKET : COMPANIES WITH PIPELINE PRODUCT
    • TERIPARATIDE
      • Table TERIPARATIDE ACETATE MARKET: MANUFACTURERS AND BRANDS
      • Table TERIPARATIDE ACETATE MARKET: KEY PLAYERS AND BRANDS
      • TERIPARATIDE ACETATE MARKET: COMPANIES WITH PIPELINE PRODUCTS
    • LIRAGLUTIDE
      • Table LIRAGLUTIDE MARKET: KEY PLAYERS AND BRANDS
    • LEUPROLIDE ACETATE
      • Table LEUPROLIDE ACETATE MARKET: MANUFACTURERS AND BRANDS
      • Table LEUPROLIDE ACETATE MARKET: KEY PLAYERS AND BRANDS
      • LEUPROLIDE ACETATE MARKET: COMPANIES WITH PIPELINE PRODUCTS
    • OCTREOTIDE ACETATE
      • Table OCTREOTIDE ACETATE MARKET: MANUFACTURERS AND BRANDS
      • Table OCTREOTIDE ACETATE MARKET: KEY PLAYERS AND BRANDS
    • CALCITONIN-SALMON
      • Table CALCITONIN-SALMON MARKET: MANUFACTURERS AND BRANDS
      • Table CALCITONIN-SALMON MARKET: KEY PLAYERS AND BRANDS
    • TRIPTORELIN
      • Table TRIPTORELIN MARKET: MANUFACTURERS AND BRANDS
      • Table TRIPTORELIN MARKET: KEY PLAYERS AND BRANDS
    • EPTIFIBATIDE
      • Table EPTIFIBATIDE MARKET: MANUFACTURERS AND BRANDS
      • Table EPTIFIBATIDE MARKET: KEY PLAYERS AND BRANDS
    • GLATIRAMER ACETATE
      • Table GLATIRAMER ACETATE MARKET: MANUFACTURERS AND BRANDS
      • Table GLATIRAMER ACETATE MARKET: KEY PLAYERS AND BRANDS
    • BIVALIRUDIN
      • Table BIVALIRUDIN MARKET: MANUFACTURERS AND BRANDS
      • Table BIVALIRUDIN MARKET: KEY PLAYERS AND BRANDS
    • GLUCAGON
      • Table GLUCAGON MARKET: KEY PLAYERS AND BRANDS
    • EXENATIDE
      • Table EXENATIDE MARKET: KEY PLAYERS AND BRANDS
      • EXENATIDE MARKET: COMPANEIS WITH PIPELINE PRODUCTS
    • OTHER MOLECULES
      • Table COLISTIN MOLECULE: MANUFACTURERES AND BRANDS
      • Table COLISTIN MARKET: KEY PLAYERS AND BRANDS
      • Table ENALAPRIL MOLECULE: MANUFACTURERES AND BRANDS
      • Table ENALAPRIL MARKET: KEY PLAYERS AND BRANDS
      • Table CASPOFUNGIN: MANUFACTURERES AND BRANDS
      • Table CASPOFUNGIN MARKET: KEY PLAYERS AND BRANDS
      • Table BORTEZOMIB: MANUFACTURERES AND BRANDS
      • Table BORTEZOMIB MARKET: KEY PLAYERS AND BRANDS
      • Table OXYTOCIN: MANUFACTURERS AND BRANDS
      • Table OXYTOCIN MARKET: KEY PLAYERS AND BRANDS
  • INDIAN PEPTIDES MARKET, BY APPLICATION
    • INTRODUCTION
      • Table INDIAN PEPTIDES MARKET SIZE, BY APPLICATION, 2016-2022 (USD MILLION)
    • DIABETES
    • INFECTIOUS DISEASES
    • CANCER
      • Table INCIDENCE OF CANCER CASES IN INDIA, 2015 VS 2025
    • OSTEOPOROSIS
    • CARDIOLOGY
    • GYNECOLOGY
    • OTHER APPLICATIONS
  • INDIAN PEPTIDES MARKET SHARE ANALYSIS
  • INDIAN PEPTIDES MARKET COMPANY PROFILES
    • BIOCON LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • SUN PHARMACEUTICAL INDUSTRIES LTD.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
    • WOCKHARDT LTD.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
    • INTAS PHARMACEUTICALS LTD.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
    • CIPLA LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • EMCURE PHARMACEUTICALS PVT. LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • ZYDUS CADILA
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
    • BHARAT SERUM AND VACCINES LIMITED
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
    • NATCO PHARMA LIMITED
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
    • DR. REDDY'S LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
  • INDIAN HEPARIN MARKET OVERVIEW
    • INTRODUCTION
    • INDIAN HEPARIN MARKET DYNAMICS
      • DRIVERS
      • RESTRAINT
      • CHALLENGE
  • INDIAN HEPARIN MARKET, BY TYPE
    • INTRODUCTION
      • Table INDIAN HEPARIN MARKET, BY TYPE, 2016-2022 (USD MILLION)
    • ENOXAPARIN SODIUM
      • Table ENOXAPARIN SODIUM MARKET: MANUFACTURERS AND BRANDS
      • Table ENOXAPARIN SODIUM MARKET: KEY PLAYERS AND BRANDS
    • HEPARIN SODIUM
      • Table HEPARIN SODIUM MARKET: MANUFACTURERS AND BRANDS
      • Table HEPARIN SODIUM MARKET: KEY PLAYERS AND BRANDS
    • FONDAPARINUX
      • Table FONDAPARINUX MARKET: MANUFACTURERS AND BRANDS
      • Table FONDAPARINUX MARKET: KEY PLAYERS AND BRANDS
    • DALTEPARIN SODIUM
      • Table DALTEPARIN SODIUM MARKET: MANUFACTURERS AND BRANDS
      • Table DALTEPARIN SODIUM MARKET: KEY PLAYERS AND BRANDS
  • INDIAN HEPARIN MARKET SHARE ANALYSIS
  • INDIAN HEPARIN MARKET COMPANY PROFILES
    • CIPLA LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • KEY INSIGHTS FROM PRIMARY INTERVIEWS
    • EMCURE PHARMACEUTICALS PVT. LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • GLAND PHARMA LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • KEY INSIGHTS FROM PRIMARY INTERVIEWS
    • TROIKAA PHARMACEUTICALS LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • KEY INSIGHTS FROM PRIMARY INTERVIEWS
    • BIOLOGICAL E LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • BHARAT BIOTECH
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • SAMARTH LIFE SCIENCES PVT. LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • KEY INSIGHTS FROM PRIMARY INTERVIEWS
    • VHB LIFE SCIENCES LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • KEY INSIGHTS FROM PRIMARY INTERVIEWS
    • CELON LABORATORIES PVT. LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • UNITED BIOTECH (P) LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report